Mr. Shane Bishop reports

CUSTOM HEALTH ANNOUNCES STRATEGIC LEADERSHIP APPOINTMENTS TO SUPPORT CONTINUED GROWTH AND REGULATORY EXCELLENCE

Custom Health Holdings Inc. has appointed Robert Guzman as chief compliance and regulatory officer, and Brent Herman as executive vice-president, corporate development.

• Mr. Guzman has been appointed chief compliance and regulatory officer, bringing extensive experience in regulatory oversight, compliance management and quality assurance to strengthen Custom Health's governance framework and support the company's continued expansion across highly regulated health care and pharmacy markets.
• Mr. Herman, founder, president and chief executive officer of InnovativeRx U.S. Holdings Inc., has been appointed executive vice-president, corporate development, bringing more than 35 years of experience in health care, pharmacy operations, corporate finance, mergers and acquisitions, and strategic growth initiatives across North America.

Shane Bishop, chief executive officer of Custom Health, commented: "We are pleased to welcome Robert and Brent to the Custom Health leadership team at an important stage in our growth. Robert's expertise in compliance, regulatory affairs and governance will further strengthen our operational foundation as we continue to scale across North America. Brent brings decades of experience building, financing, and growing health care and pharmacy businesses, and his strategic leadership will be invaluable as we pursue new partnerships, acquisitions and growth opportunities. Together, their experience enhances our ability to execute on our long-term vision of transforming health care delivery through technology-enabled pharmacy and clinical care solutions."

Robert Guzman appointed chief compliance and regulatory officer

Custom Health is pleased to announce the appointment of Mr. Guzman as chief compliance and regulatory officer.

Mr. Guzman is an attorney, licensed engineer and regulatory affairs executive with more than 25 years of experience leading compliance, quality assurance, regulatory affairs, international trade and corporate governance functions across the health care, pharmaceutical, biotechnology and medical device sectors. He has held senior leadership positions with global health care organizations, including Getinge, C.R. Bard and Chimerix, where he led regulatory strategy, health care compliance, quality systems and international regulatory initiatives. Mr. Guzman worked closely with the U.S. Food and Drug Administration (FDA) in the development and implementation of the unique device identification (UDI) regulation for medical devices, helping advance industry-wide device traceability and patient safety initiatives. While serving as vice-president of compliance at Chimerix, he also led critical drug supply efforts during the Ebola crisis in Liberia in collaboration with the Bill & Melinda Gates Foundation, supporting the delivery of investigational therapies in response to the public health emergency.

Most recently, Mr. Guzman served as senior director and counsel at Getinge, advising business units across North America, Europe, Asia-Pacific, the Middle East, Africa and Latin America on regulatory affairs, compliance, international trade, corporate transactions and strategic growth initiatives. Earlier in his career, he served as vice-president, quality assurance and compliance officer at Chimerix, and senior director, regulatory affairs, at C.R. Bard.

Mr. Guzman holds a Juris Doctor (JD) from the Pontifical Catholic University of Puerto Rico School of Law, a master of laws (LLM) in corporate and commercial law from the University of London, a master of science in life and chemical sciences from the University of Maryland, College Park, a master of business administration (MBA) from the University of Massachusetts Lowell, and a bachelor of science in industrial engineering from the Polytechnic University of Puerto Rico.

As chief compliance and regulatory officer, Mr. Guzman will lead the company's compliance, regulatory, quality assurance and governance functions, supporting Custom Health's continued growth within highly regulated health care and pharmacy markets across North America.

Mr. Guzman commented: "I am excited to join Custom Health at such a transformative time in the company's growth. Custom Health has developed an innovative health care platform that combines technology, pharmacy services and clinical expertise to improve patient outcomes. I look forward to strengthening the company's compliance and regulatory framework while supporting its continued expansion and commitment to delivering high-quality, patient-centred care across North America."

Brent Herman appointed executive vice-president, corporate development

Custom Health is pleased to announce the appointment of Mr. Herman as executive vice-president, corporate development.

Mr. Herman currently serves as president and chief executive officer of InnovativeRx U.S. Holdings Inc., a closed-door long-term care pharmacy group that he founded in 2011 and which was recently acquired by Custom Health. He brings more than 35 years of experience founding, structuring, financing, operating and advising companies across a broad range of industries, including pharmacy and health care, throughout Canada, the United States and internationally.

Prior to founding InnovativeRx, Mr. Herman was a securities partner at Burnet, Duckworth & Palmer LLP, where he maintained a broad corporate and securities law practice advising public and private corporations, trusts, limited partnerships, investment funds, dealers and advisers. During his legal career, he developed extensive expertise in corporate finance, capital markets, mergers and acquisitions, public and private financings, regulatory compliance, and corporate governance.

As executive vice-president, corporate development, Mr. Herman will focus on advancing strategic growth initiatives, expanding industry partnerships, identifying acquisition opportunities and supporting the continued development of Custom Health's integrated health care platform across North America.

Mr. Herman commented: "I am excited to join Custom Health and contribute to the company's vision of transforming health care delivery through technology-enabled pharmacy and clinical care solutions. Custom Health has built a differentiated platform with significant growth opportunities ahead, and I look forward to working with the leadership team to help accelerate the company's strategic objectives."

About Custom Health Holdings Inc.

Custom Health is an AI-enabled health care technology company that operates an infrastructure platform designed to ensure medication therapy works as intended. Custom Health provides continuous visibility into a patient's therapy by deploying and operating in-home technology, pharmacy and pharmacist-led clinical services to capture real-world data and deliver continuing clinical oversight and action. Powered by the proprietary AdhereNet platform, Custom Health operates an integrated pharmacy network across Canada and the United States as part of its broader infrastructure, enabling medication delivery, continuous monitoring and earlier clinical intervention to improve outcomes.